Hubhopper - Robust and Easy to Create and Distribute Podcasts

FDA D.I.S.C.O.: L-glutamine for sickle cell disease

About

FDA D.I.S.C.O.: L-glutamine for sickle cell disease. FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

February 28, 2020

Science

FDA D.I.S.C.O.: L-glutamine for sickle cell disease. FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.